MED-LIFE DISCOVERIES
Plasmalogens RCDP Neurological
PlasmalogensRCDPNeurological
MED-LIFE DISCOVERIES
Plasmalogen Replacement Therapy
Plasmalogen Replacement Therapy
Kaeli KnudsenJanuary 5, 2022
First 50 Blogs
First 50 Blogs
Kaeli KnudsenDecember 15, 2021
Neurotransmitter release: The last millisecond in the life of a synaptic vesicle
Neurotransmitter release: The last millisecond in the life of a synaptic vesicle
Kaeli KnudsenNovember 30, 2021
Lipid rafts and neurodegeneration: structural and functional roles in physiologic aging and neurodegenerative diseases.
Lipid rafts and neurodegeneration: structural and functional roles in physiologic aging and neurodegenerative diseases.
Kaeli KnudsenNovember 17, 2021
Animal models of Alzheimer's disease
Animal models of Alzheimer's disease
Kaeli KnudsenOctober 25, 2021
A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers.
A/T/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers.
Kaeli KnudsenOctober 13, 2021
A mouse model system to study peroxisomal roles in neurodegeneration of peroxisome biogenesis disorders
A mouse model system to study peroxisomal roles in neurodegeneration of peroxisome biogenesis disorders
Kaeli KnudsenOctober 5, 2021
Oral supplementation of an alkylglycerol mix comprising different alkyl chains effectively modulates multiple endogenous plasmalogen species in mice
Oral supplementation of an alkylglycerol mix comprising different alkyl chains effectively modulates multiple endogenous plasmalogen species in mice
Kaeli KnudsenSeptember 28, 2021
Neuroprotective effects of scallop-derived plasmalogen in a mouse model of ischemic stroke
Neuroprotective effects of scallop-derived plasmalogen in a mouse model of ischemic stroke
Kaeli KnudsenSeptember 15, 2021
Plasmalogen attenuates the development of hepatic steatosis and cognitive deficit through mechanism involving p75NTR inhibition.
Plasmalogen attenuates the development of hepatic steatosis and cognitive deficit through mechanism involving p75NTR inhibition.
Kaeli KnudsenSeptember 1, 2021
Plasmalogens regulate the AKT-ULK1 signaling pathway to control the position of the axon initial segment.
Plasmalogens regulate the AKT-ULK1 signaling pathway to control the position of the axon initial segment.
Kaeli KnudsenAugust 19, 2021
Shark liver oil supplementation enriches endogenous plasmalogens and reduces markers of dyslipidaemia and inflammation
Shark liver oil supplementation enriches endogenous plasmalogens and reduces markers of dyslipidaemia and inflammation
Kaeli KnudsenAugust 3, 2021
Endothelial ether lipids link the vasculature to blood pressure, behavior, and neurodegeneration
Endothelial ether lipids link the vasculature to blood pressure, behavior, and neurodegeneration
Kaeli KnudsenJuly 21, 2021
Coronavirus-induced host cubic membranes and lipid-related antiviral therapies: A focus on bioactive plasmalogens
Coronavirus-induced host cubic membranes and lipid-related antiviral therapies: A focus on bioactive plasmalogens
Kaeli KnudsenJuly 7, 2021
The potential role of bioactive plasmalogens in lung surfactant
The potential role of bioactive plasmalogens in lung surfactant
Kaeli KnudsenJune 16, 2021
Clinical RCDP discoveries in the last decade
Clinical RCDP discoveries in the last decade
Kaeli KnudsenMay 28, 2021
The benefit of animal models in RCDP research
The benefit of animal models in RCDP research
Kaeli KnudsenMay 26, 2021
Clinical, biochemical and molecular characterization of mild (nonclassic) Rhizomelic Chondrodysplasia Punctata
Clinical, biochemical and molecular characterization of mild (nonclassic) Rhizomelic Chondrodysplasia Punctata
Kaeli KnudsenMay 20, 2021
A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform
A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform
Kaeli KnudsenMay 11, 2021
A peroxisomal disorder of severe intellectual disability, epilepsy, and cataracts due to fatty acyl-CoA reductase 1 deficiency
A peroxisomal disorder of severe intellectual disability, epilepsy, and cataracts due to fatty acyl-CoA reductase 1 deficiency
Kaeli KnudsenMay 6, 2021
Newer Older

© 2024 MED-LIFE DISCOVERIES LP

Suite 407, 15 Innovation BLVD
Saskatoon, SK Canada. S7N 2X8 306-244-8233

Corporate
News Legal